Raffael Liegl
Papers
7
Total Citations
72
H-Index
6
About
Raffael Liegl is a pioneering ophthalmic surgeon and researcher whose work centers on the application of robotic-assisted stereotactic radiosurgery—specifically the CyberKnife platform—for the treatment of complex intraocular tumors. His primary research areas include uveal melanoma (choroidal, ciliary body, and iris), choroidal metastasis, and rare vasoproliferative tumors. Liegl’s major contribution is the systematic validation of CyberKnife radiosurgery as a precise, non-invasive alternative to traditional plaque brachytherapy or enucleation. His 2023 landmark study on robotic CyberKnife radiosurgery for choroidal and ciliary body melanoma (27 citations) established key safety and efficacy benchmarks. He further advanced the field by identifying risk factors for local recurrence in choroidal melanoma (11 citations), directly linking treatment parameters to patient survival outcomes. His work on small choroidal melanomas and iris melanoma has expanded treatment options for anatomically challenging cases. With over 70 total citations across his core publications, Liegl’s research has provided critical evidence for integrating robotic radiosurgery into ocular oncology, offering patients vision-preserving therapy with reduced morbidity. His studies remain essential reading for clinicians and researchers advancing stereotactic techniques in ophthalmology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Robotic CyberKnife radiosurgery for small choroidal melanomas7 citations · 2022
- 5
- 6Robotic CyberKnife Radiosurgery for Ciliary Body Melanoma6 citations · 2020
- 7